“A Case Report on Prolonged Response With Trastuzumab Emtansine (T-DM1) in Recurrent Advance Breast Cancer Setting”. Journal of Cancer Research Updates, vol. 12, Dec. 2023, pp. 49-53, https://doi.org/10.30683/1929-2279.2023.12.9.